Ampio Pharmaceuticals Inc (NYSE MKT LLC:AMPE)

2.73
Delayed Data
As of Apr 24
 -0.16 / -5.54%
Today’s Change
2.49
Today|||52-Week Range
9.01
-20.41%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$141.9M

Company Description

Ampio Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development of therapies to treat prevalent inflammatory conditions. Its product pipeline includes new uses for approved drugs and new molecular entities for important therapeutic areas, including metabolic disease, eye disease, kidney disease, inflammation, sexual dysfunction and CNS disease. The company intends to maintain a diversified product candidate pipeline to mitigate risks associated with pharmaceutical development which capitalizes on its internal discoveries and intellectual property, which includes owned and assigned patents, filed patent applications, exclusive licenses, and trade secrets and know-how, some of which may be the subject of future patent applications. Its intellectual property focuses on three primary areas: new indications for previously approved drugs, New Molecular Entities, and rapid point-of-care tests for diagnosis, monitoring and screening. Ampio Pharmaceuticals was founded by Michael Macaluso in March 2008 and is headquartered in Greenwood Village, CO.

Contact Information

Ampio Pharmaceuticals, Inc.
5445 DTC Parkway
Greenwood Village Colorado 80111
P:(720) 437-6500
Investor Relations:
(720) 437-6530

Employees

Shareholders

Mutual fund holders7.61%
Other institutional23.36%
Individual stakeholders10.82%

Top Executives

Michael MacalusoChairman & Chief Executive Officer
Gregory A. GouldChief Financial Officer, Secretary & Treasurer
David Bar-OrDirector & Chief Scientific Officer
Rick GilesDirector-Investor Relations
Vaughan Lennox CliftChief Regulatory Affairs Officer

To view my watchlist

Not a member yet?

Sign up now for a free account